Novocure
Dr. Nicole Friedersdorf currently serves as the Director of Marketing for New Indications Oncology at Novocure, a position held since February 2023. Prior to this role, Dr. Friedersdorf accumulated significant experience at IQVIA, where responsibilities included Director of Global Patient & Site Solutions and Director of Marketing, Product & Brand Strategy in Global Oncology. Earlier career milestones include serving as a Senior Consultant at Brand Strategy & Business Development and as a Product Manager for Oncology at IMS Health. Dr. Friedersdorf began their career in the oncology field with roles as a Medical Manager at Merck-Serono and as a postdoctoral researcher at Universitätsmedizin Mainz, following a doctoral research stint at the German Cancer Research Center. Dr. Friedersdorf holds a Diplom Biologe degree in Microbiology and Immunology from Technische Universität Darmstadt.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.